Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Surgical Considerations of Intractable Mesial Temporal Lobe Epilepsy.

Boling WW.

Brain Sci. 2018 Feb 20;8(2). pii: E35. doi: 10.3390/brainsci8020035. Review.

2.

Epilepsy Treatment: A Futurist View.

Privitera M.

Epilepsy Curr. 2017 Jul-Aug;17(4):204-213. doi: 10.5698/1535-7597.17.4.204.

3.

Quantitative Measurement of Longitudinal Relaxation Time (qT1) Mapping in TLE: A Marker for Intracortical Microstructure?

Hogan RE.

Epilepsy Curr. 2017 Nov-Dec;17(6):358-360. doi: 10.5698/1535-7597.17.6.358. No abstract available.

4.

Pre- and post-operative Wisconsin card sorting test performance in patients with temporal lobe epilepsy due to hippocampal sclerosis.

Tisser L, Palmini A, Paglioli E, Portuguez M, Azambuja N, da Costa JC, Paglioli E, Torres C, Martinez JV.

Dement Neuropsychol. 2007 Apr-Jun;1(2):173-180. doi: 10.1590/s1980-57642008dn10200010.

5.

Quantitative surface analysis of combined MRI and PET enhances detection of focal cortical dysplasias.

Tan YL, Kim H, Lee S, Tihan T, Ver Hoef L, Mueller SG, Barkovich AJ, Xu D, Knowlton R.

Neuroimage. 2018 Feb 1;166:10-18. doi: 10.1016/j.neuroimage.2017.10.065. Epub 2017 Oct 31.

PMID:
29097316
6.

Can we predict drug response by volumes of the corpus callosum in newly diagnosed focal epilepsy?

Kim HC, Kim SE, Lee BI, Park KM.

Brain Behav. 2017 Jun 21;7(8):e00751. doi: 10.1002/brb3.751. eCollection 2017 Aug.

7.

Molecular isoforms of high-mobility group box 1 are mechanistic biomarkers for epilepsy.

Walker LE, Frigerio F, Ravizza T, Ricci E, Tse K, Jenkins RE, Sills GJ, Jorgensen A, Porcu L, Thippeswamy T, Alapirtti T, Peltola J, Brodie MJ, Park BK, Marson AG, Antoine DJ, Vezzani A, Pirmohamed M.

J Clin Invest. 2017 Jun 1;127(6):2118-2132. doi: 10.1172/JCI92001. Epub 2017 May 15.

8.

Cause of death in patients with poststroke epilepsy: Results from a nationwide cohort study.

Hansen J, Åsberg S, Kumlien E, Zelano J.

PLoS One. 2017 Apr 5;12(4):e0174659. doi: 10.1371/journal.pone.0174659. eCollection 2017.

9.

Inflammation in epileptogenesis after traumatic brain injury.

Webster KM, Sun M, Crack P, O'Brien TJ, Shultz SR, Semple BD.

J Neuroinflammation. 2017 Jan 13;14(1):10. doi: 10.1186/s12974-016-0786-1. Review.

10.

A Prediction Algorithm for Drug Response in Patients with Mesial Temporal Lobe Epilepsy Based on Clinical and Genetic Information.

Silva-Alves MS, Secolin R, Carvalho BS, Yasuda CL, Bilevicius E, Alvim MK, Santos RO, Maurer-Morelli CV, Cendes F, Lopes-Cendes I.

PLoS One. 2017 Jan 4;12(1):e0169214. doi: 10.1371/journal.pone.0169214. eCollection 2017.

11.

Preoperative automated fibre quantification predicts postoperative seizure outcome in temporal lobe epilepsy.

Keller SS, Glenn GR, Weber B, Kreilkamp BA, Jensen JH, Helpern JA, Wagner J, Barker GJ, Richardson MP, Bonilha L.

Brain. 2017 Jan;140(1):68-82. doi: 10.1093/brain/aww280. Epub 2016 Nov 15.

12.

Sleep-related hypermotor epilepsy: Long-term outcome in a large cohort.

Licchetta L, Bisulli F, Vignatelli L, Zenesini C, Di Vito L, Mostacci B, Rinaldi C, Trippi I, Naldi I, Plazzi G, Provini F, Tinuper P.

Neurology. 2017 Jan 3;88(1):70-77. doi: 10.1212/WNL.0000000000003459. Epub 2016 Nov 23.

13.

Managing drug-resistant epilepsy: challenges and solutions.

Dalic L, Cook MJ.

Neuropsychiatr Dis Treat. 2016 Oct 12;12:2605-2616. eCollection 2016. Review.

14.
15.

Adenosine A2A receptor and ecto-5'-nucleotidase/CD73 are upregulated in hippocampal astrocytes of human patients with mesial temporal lobe epilepsy (MTLE).

Barros-Barbosa AR, Ferreirinha F, Oliveira Â, Mendes M, Lobo MG, Santos A, Rangel R, Pelletier J, Sévigny J, Cordeiro JM, Correia-de-Sá P.

Purinergic Signal. 2016 Dec;12(4):719-734. Epub 2016 Sep 20.

16.

Are "Theory of Mind" Skills in People with Epilepsy Related to How Stigmatised They Feel? An Exploratory Study.

Noble AJ, Robinson A, Marson AG.

Behav Neurol. 2016;2016:5025174. doi: 10.1155/2016/5025174. Epub 2016 Aug 18.

17.

Clinical characteristics of patients with benign nonlesional temporal lobe epilepsy.

Kim J, Kim SH, Lim SC, Kim W, Shon YM.

Neuropsychiatr Dis Treat. 2016 Jul 28;12:1887-91. doi: 10.2147/NDT.S110400. eCollection 2016.

18.

Chemogenetic silencing of the midline and intralaminar thalamus blocks amygdala-kindled seizures.

Wicker E, Forcelli PA.

Exp Neurol. 2016 Sep;283(Pt A):404-12. doi: 10.1016/j.expneurol.2016.07.003. Epub 2016 Jul 9.

19.

Update on the role of eslicarbazepine acetate in the treatment of partial-onset epilepsy.

Tambucci R, Basti C, Maresca M, Coppola G, Verrotti A.

Neuropsychiatr Dis Treat. 2016 May 23;12:1251-60. doi: 10.2147/NDT.S86765. eCollection 2016. Review.

20.

Altered GABAA receptor density and unaltered blood-brain barrier [11C]flumazenil transport in drug-resistant epilepsy patients with mesial temporal sclerosis.

Froklage FE, Postnov A, Yaqub MM, Bakker E, Boellaard R, Hendrikse NH, Comans EF, Schuit RC, Schober P, Velis DN, Zwemmer J, Heimans JJ, Lammertsma AA, Voskuyl RA, Reijneveld JC.

J Cereb Blood Flow Metab. 2017 Jan;37(1):97-105. Epub 2015 Nov 19.

Supplemental Content

Support Center